J.P. Morgan


J.P. Morgan Reiterates Overweight on SAGE Therapeutics Inc (SAGE) Following Positive Top-Line Phase 2 Data

In a research report released on Monday, J.P.

Stock Giants in the Limelight: Apple Inc. (AAPL) and Tesla Motors Inc (TSLA)

Technology enthusiasts have a lot to look forward to this week as smartphone giant Apple Inc. (NASDAQ:AAPL) hosts its annual Worldwide Developers Conference and …

Wall Street’s Week Ahead: NVIDIA Corporation (NVDA), SolarCity Corp (SCTY), Nokia Corp (ADR) (NOK), and Walt Disney Co (DIS)

Investors are anticipating this week’s expected earning releases from NVIDIA Corporation (NASDAQ:NVDA), SolarCity Corp (NASDAQ:SCTY) , Nokia Corp (ADR) (NYSE:NOK), and Walt Disney Co (NYSE:DIS). See how analysts are weighing …

Alibaba Group Holding Ltd (BABA) and Paypal Holdings Inc (PYPL) on Analysts’ Radars Due to E-Commerce Growth

What does the future hold for Alibaba Group Holding Ltd (NYSE:BABA) and Paypal Holdings Inc (NASDAQ:PYPL)? Analysts weigh in on the two companies, …

J.P. Morgan Cuts Price Target For Puma Biotechnology Inc (PBYI) Following NDA Delay; Remains Positive

Shareholders of Puma Biotechnology Inc (NYSE:PBYI) are having a rough day as the company’s stock is down 23%, following the news that the company will …

Biotech Roundup: Celldex Therapeutics, Inc. (CLDX), Keryx Biopharmaceuticals (KERX), BioDelivery Sciences International, Inc. (BDSI)

Biotech stocks are notoriously volatile as a pipeline update or FDA announcement can instantly send share prices through the roof. Below, analysts weigh …

J.P. Morgan Heads to Sidelines on PTC Therapeutics, Inc. (PTCT) Amid FDA Setback; Slashes Price Target

Tuesday turned out to be a nightmare for shareholders of PTC Therapeutics, Inc. (NASDAQ:PTCT) as the stock price tumbled over 55%, after the biotech company received …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts